GALNT2 and coronary artery disorder: The promoter region of the ABCG1, GALNT2 and HMGCR genes was hypermethylated in 90.5%, 54.1% and 34.1% of CHD patients and 29.6%, 27.8% and 22.2% of non-CHD subjects.